Orexo Pharmaceuticals was founded in 1995. In 2003, the company acquired CePeP. Orexo Pharmaceuticals' vision is to be seen as a leader in the development of patented pharmaceuticals that significantly improve patient care, based on innovative drug delivery. The company intends to meet its vision by forming partnerships with established marketing and sales organisations by offering health providers new, improved therapeutic treatment alternatives. Orexo's strategy for developing new products is to combine well-documented substances with technologies that the company has invented, developed or acquired. One of the characteristics shared by all of Orexo's existing technological platforms is that they help improve the patient's quality of life
R&D
To view this information, you must subscribe to Partneringtools.
Partnerships
To view this information, you must subscribe to Partneringtools.
Deals
To view this information, you must subscribe to Partneringtools.
Latest News
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Board of directors
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.
Industry news: Pharmalicensing provides comprehensive industry coverage.